News

PMB attended the 7th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies, held in conjunction with the 30th Society for Neuro-Oncology Annual Meeting & Education Day in beautiful Honolulu, Hawaii! This year’s meeting was particularly special, as it marks SNO’s 30th anniversary—a milestone that underscores three decades of progress, collaboration, and innovation in neuro-oncology. The meeting took place Nov. 19-23, 2025.

The 17th COGNO Annual Scientific Meeting (ASM), New Horizons, Novel Therapies, held from Sunday 14 to Tuesday 16 September 2025 at The Langham Gold Coast, Queensland, was a resounding success. The conference spotlighted cutting-edge treatments…

PMB participated in the LSX USA Congress in Boston on September 16–17, where we engaged in dynamic conversations around biotech innovation and next-generation therapeutics. The event provided a valuable platform to connect with leaders in oncology, biologics, and investment, fostering meaningful dialogue on the future of neuro-oncology.

We highlighted Immune12, our groundbreaking marine-sourced complex biologic targeting Glioblastoma (GBM), one of the most aggressive forms of brain cancer. The conference proved to be a productive opportunity to share insights, explore strategic collaborations, and advance our mission to transform outcomes for patients facing GBM.